Correspondents say that the measure is the the on it is not easy at the problem, after sharp criticism from the Socialist opposition and health professionals.

Said , however, Dr. Chaillet Chaillet of the St Antoine hospital in Paris BBC News Online that the situation could partly be blamed on an aging population, but partly on the state of health care.Geron, the U.S. economy as has , is not ideal of diversification of and the company decided to more on your more on its core competencies of area – oncology. – John A. Scarlett, MD, CEO Geron Corporation, said:.

Geron says there is on partners financial resources than well as seek technical know-how of further developing their stem cells program. Scarlettrose said: – permit Geron seeking partners with which technical and financial resources for the development of stem programs. ‘Our staff, employees and shareholders to be proud of the pioneering role they performed our stem cell technology to clinical development have stem cell continue maintaining great medical promise of.